Nearly 5% of patients with cancer die within 1 month of undergoing surgery
the ONA take:
According to new findings presented at the American Society of Clinical Oncology's (ASCO's) 2014 Quality Care Symposium in Boston, Massachusetts, researchers have found that of the more than 1.1 million patients with cancer who underwent surgery, nearly 5% died within 1 month of their surgery.
For the study, the researchers identified more than 1.1 million patients diagnosed with cancer between 2004 and 2001. Of those, 53,498 patients died within the month after undergoing the operation.
In addition, researchers found that married patients had a 20% lower risk of dying within 1 month after surgery compared to unmarried patients. Insured patients had a 12% lower risk of dying within 1 month after surgery compared with uninsured patients, and wealthier patients had a 5% lower risk.
Also, more educated patients had a 2% lower risk of dying compared with less educated patients. In contrast, minority patients had a 13% higher risk of dying within 1 month after surgery, men had an 11% higher risk, and older patients had a 2% higher risk. Patients with advanced cancer had an 89% greater risk of dying within 1 month after surgery. The findings suggest that disparities affect adversely affect surgical outcomes.
Of more than 1.1 million patientswho underwent surgery, nearly 5% died within 1 month.
In a study of more than 1.1 million cancer patients who had surgery, Harvard researchers found that almost 5 percent died within one month of their operation. These findings are scheduled to be presented at the American Society of Clinical Oncology's 2014 Quality Care Symposium, held from Oct. 17 to 18 in Boston. The researchers found that, of the 1.1 million patients diagnosed from 2004 to 2011, 53,498 died within the month after surgery.
Specifically, married patients had a 20 percent lower risk of dying within the month after surgery; insured patients had a 12 percent lower risk; wealthier patients had a 5 percent lower risk; and more-educated patients had a 2 percent lower risk. Conversely, minority patients had a 13 percent higher risk of dying; men had an 11 percent greater risk; older patients had a 2 percent greater risk; and patients with advanced cancer had an 89 percent higher risk.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|